Search details
1.
The CLIP1-LTK fusion is an oncogenic driverĀ in non-small-cell lung cancer.
Nature
; 600(7888): 319-323, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34819663
2.
REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.
Am J Pathol
; 192(6): 847-861, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35367201
3.
S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
Ann Surg Oncol
; 29(13): 8198-8206, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36097299
4.
Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data.
BMC Pulm Med
; 22(1): 31, 2022 Jan 09.
Article
in English
| MEDLINE | ID: mdl-35000608
5.
Metabolic changes induced by TGF-Ć1 via reduced expression of phosphatidylserine decarboxylase during myofibroblast transition.
J Clin Biochem Nutr
; 70(2): 108-116, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35400823
6.
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050.
Future Oncol
; 17(7): 783-794, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33164569
7.
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Lancet Oncol
; 21(6): 843-850, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32502444
8.
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study.
Cancer Sci
; 111(7): 2488-2498, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32426898
9.
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Cancer Sci
; 111(5): 1724-1738, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32159882
10.
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study.
Cancer Sci
; 111(10): 3726-3738, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32681682
11.
Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
Jpn J Clin Oncol
; 49(7): 614-619, 2019 Jul 01.
Article
in English
| MEDLINE | ID: mdl-30916304
12.
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.
Jpn J Clin Oncol
; 48(1): 31-42, 2018 Jan 01.
Article
in English
| MEDLINE | ID: mdl-29136201
13.
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(11): 1454-1466, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28958502
14.
Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma.
Cancer Sci
; 108(1): 136-142, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27761967
15.
ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
Ann Surg Oncol
; 29(13): 8209-8210, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36209323
16.
Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer.
Cancer Sci
; 107(3): 315-9, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26748638
17.
Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
Jpn J Clin Oncol
; 46(11): 1008-1014, 2016 Nov 01.
Article
in English
| MEDLINE | ID: mdl-27511988
18.
Docetaxel for platinum-refractory advanced thymic carcinoma.
Jpn J Clin Oncol
; 45(7): 665-9, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25840444
19.
Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.
Jpn J Clin Oncol
; 45(10): 941-6, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26232449
20.
[Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
Gan To Kagaku Ryoho
; 42(2): 144-7, 2015 Feb.
Article
in Japanese
| MEDLINE | ID: mdl-25743132